Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

184

...

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
B01AD11	METALYSE	BioTech	Tenecteplase - 10,000IU	10,000IU	Injectable powder for solution+diluent	72,657,303 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	38,763,115 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 2g	2g	Injectable powder for solution	77,527,404 L.L
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 500IU	500IU	Injectable lyophilised powder for solution+diluent	38,762,207 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 500IU	500U (50U/ml)	Injectable powder for solution+solvent	37,797,298 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 1000IU	1000U (50U/ml)	Injectable powder for solution+solvent	74,575,183 L.L
B02BD04	IMMUNINE	BioHuman	Plasma coagulation factor IX, human - 600IU	600IU	Injectable lyophilised powder for solution+diluent	20,506,214 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 2mg	2mg (100KIU)	Injectable powder for solution+diluent	102,980,708 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 1mg	1mg (50KIU)	Injectable powder for solution+diluent	56,263,955 L.L
B02BD08	NOVOSEVEN RT	BioTech	Eptacog alfa (activated) recombinant - 5mg	5mg (250KIU)	Injectable powder for solution+diluent	257,452,982 L.L
B02BD08	RECOFACT VII	BioTech	Eptacog alfa (activated) recombinant - 1.2mg	1.2mg	Injectable powder for solution+diluent	47,533,131 L.L
B02BX04	NPLATE	BioTech	Romiplostim - 250mcg	250mcg	Injectable powder for solution	67,369,332 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	78,295,560 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 25mg	25mg	Tablet, film coated	78,295,560 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	143,306,217 L.L
B02BX05	REVOLADE	B	Eltrombopag Olamine - 50mg	50mg	Tablet, film coated	143,306,217 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 60mg/0.4ml	60mg/0.4ml	Injectable solution	352,833,901 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	179,668,577 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 150mg/ml	150mg/ml	Injectable solution	716,437,779 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 105mg/0.7ml	105mg/0.7ml	Injectable solution	577,741,643 L.L
B03XA01	EPREX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU/0.4ml	4,000IU/0.4ml	Injectable solution	15,187,737 L.L
B03XA01	EPOTIN	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU/ml	4,000IU/ml	Injectable solution	16,886,730 L.L
B03XA02	ARANESP	BioTech	Darbepoetin alfa - 20mcg	20mcg	Injectable solution	15,952,913 L.L
C01BG11	BRINAVESS	B	Vernakalant - 20mg/ml	20mg/ml	Injectable concentrated solution	41,821,582 L.L
C01BG11	BRINAVESS	B	Vernakalant - 20mg/ml	20mg/ml	Injectable concentrate for solution	41,821,582 L.L
C01EA01	PROSTIN VR	B	Alprostadil - 500mcg/ml	500mcg/ml	Injectable concentrated solution	19,894,577 L.L
C02KX01	TRACLEER	B	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	79,583,961 L.L
C02KX01	TRACLEER	B	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	79,583,961 L.L
C02KX01	PMS-BOSENTAN	G	Bosentan (monohydrate) - 125mg	125mg	Tablet	78,949,300 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	71,838,717 L.L

...

184

...